Frontierby eninvs

Language: EN · RU

← Region

MD Medical USD

Update

Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.

Sector: Healthcare

RU_MDMG

Price chart

1 293.8 RUBDay -0.45%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
1 293.8 RUB · -0.45%
Market cap
1.4 bn USD

Growth

Δ revenue y/y
19.9%
Δ EBITDA y/y
19.5%

Multiples

P/E (LTM)
P/B (FY)
2.6x
P/E (ann.)
9.6x
EV/EBITDA (LTM)
11.5x
EV/EBITDA (ann.)
11.7x

Cash return

Dividend yield
3.2%
FCF yield (LTM)

Liquidity

Daily turnover (MOEX)
97.4 mln RUB

Shares: connector/market_inputs

Amounts: USD (converted) · As reported
Converted modes use NBK / ECB-linked rates: balance sheet date for BS items, period average for P&L and cash flow (see filing row evidence). As reported keeps each row in its filing currency.

🔍 Sanity check — subtotal consistency (Level-1 + Level-2) OK: 1 / Warn: 0 / Err: 8 / Autofix applied: 0
Port of PHP subtotal-total + sign-flip detection logic
PeriodIssues
2023-06-30 H1Errors 1
2023-12-31 FYErrors 1
2023-12-31 H2OK
2024-06-30 H1Errors 1Warn 2
2024-12-31 FYErrors 1Warn 1
2024-12-31 H2Errors 1Warn 1
2025-06-30 H1Errors 1Warn 1
2025-12-31 FYErrors 1Warn 2
2025-12-31 H2Errors 1Warn 2
All checks pass · Has warnings (review) · Has errors (needs fix) · ✓* Autofix applied (see evidence)

Financial dynamics

Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueM USDOperating profitM USDD&AM USDEBITDAM USDNet profitM USDOperating CFM USDCapex + M&AM USDAssetsM USDEquityM USDROE (annualized)Net debtM USDSource
2025-12-31FY 2025 (12M)PARTIAL
y/y
y/y
23.6
y/y 72.8%
y/y
y/y
124.5-40.3695.5
y/y 27.3%
514.6
y/y 19.3%
555.6
2025-06-30Q2 2025 (3M)OK270.2
y/y 22.2%
65.3
y/y 13.0%
16.4
y/y 24.3%
81.7
y/y 15.1%
71.0
y/y 3.6%
71.0-18.4661.4
y/y 1.6%
477.8
y/y 18.6%
31.2%-173.5
2024-12-31FY 2024 (12M)OK243.5
y/y 17.5%
70.1
y/y 18.0%
13.6
y/y 2.5%
84.6
y/y 16.3%
-117.9
y/y -94105.2%
86.7-18.1546.4
y/y -5.7%
431.5
y/y -11.0%
-11.8%-4448.3
2024-06-30Q2 2024 (3M)OK221.0
y/y 22.6%
57.8
y/y 25.9%
13.2
y/y 13.7%
71.0
y/y 23.5%
68.5
y/y
68.5-13.0651.0
y/y
402.9
y/y
30.9%-13157.4
2023-12-31FY 2023 (12M)OK207.3
y/y
59.4
y/y
13.3
y/y
72.7
y/y
0.1
y/y
70.3-19.5579.7
y/y
484.6
y/y
-17687.3
2023-06-30Q2 2023 (3M)PARTIAL180.3
y/y
45.9
y/y
11.6
y/y
57.5
y/y
0.1
y/y
61.2-27.0
y/y
y/y
-5834.0
Data quality — review suggested

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

01002003002023 H12023 H22024 H12024 H22025 H12025 H2

Year-over-year change

0%10%20%2023 H12023 H22024 H12024 H22025 H12025 H2

Cash flow

Net debt / cash ($ mln)

-20 000-15 000-10 000-5 00002023 H12023 FY2024 H12024 FY2025 H12025 FY

Dividends

No dividend rows found for this issuer.

Reporting forms detected in loaded periods: (Balance sheet / Profit or loss (P&L) / Cash flows)